A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults

Clinical trial NCT04614948 · COMPLETED

Trial details

NCT number: NCT04614948
Sponsor: Janssen Vaccines & Prevention B.V.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19

Start date: 2020-11-12
Primary completion: 2023-06-18
Enrollment: 31835

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.